Effect of extract from Yiyuan Yiliu Tang on human lung adenocarcinoma and human hepatoma cell lines

J Tradit Chin Med. 2021 Feb;41(1):36-43. doi: 10.19852/j.cnki.jtcm.2021.01.005.

Abstract

Objective: To investigate the efficacy of the extract from Yiyuan Yiliu Tang (, YYYLT) on human lung adenocarcinoma cells A549 and human hepatoma cells Bel7402.

Methods: The cancer cell lines were treated with various concentrations (0, 100, 200, 300, and 400 μg/mL) of the crude water extract of YYYLT and then cell viability, toxicity, cytokine secretion, and cell cycle/apoptosis were determined by MTT assay, LDH assay, and flow cytometry, respectively.

Results: The extract from YYYLT significantly suppressed the proliferation of the cancer cell lines and the release of interleukin-2 and tumor necrosis factor-α in a dose-dependent manner. The extract also promoted apoptosis, caused cell cycle arrest at G0/G1 phase, and increased the expression of caspase-3, B-cell lymphoma-2 (Bcl-2), and Bcl-2-associated X proteins.

Conclusion: The extract from YYYLT might be a potential treatment for human lung and liver cancers.

Keywords: Antineoplastic agent; Apoptosi; Cell cycle; Nodal protein; Yiyuan Yiliu Tang.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma of Lung / drug therapy*
  • Adenocarcinoma of Lung / genetics
  • Adenocarcinoma of Lung / metabolism
  • Adenocarcinoma of Lung / physiopathology
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Apoptosis / drug effects
  • Cell Cycle Checkpoints / drug effects
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Drugs, Chinese Herbal / pharmacology*
  • Humans
  • Interleukin-2 / genetics
  • Interleukin-2 / metabolism
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / physiopathology
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Antineoplastic Agents, Phytogenic
  • Drugs, Chinese Herbal
  • Interleukin-2
  • Tumor Necrosis Factor-alpha